Clinical Trial Update: A Phase II/III Study to Evaluate the Immunogenicity, Safety and Lot-to-lot Consistency of LBVD, a Fully Liquid Hexavalent Diphtheria-tetanus-whole Cell Pertussis-hepatitis B-poliovirus-Haemophilus Influenzae Type b Conjugate (DTwP-HepB-IPV-Hib) Vaccine, in Healthy Infants as Primary Series [Phase 2, Phase 3]

View source ↗

Summary

Phase II/III trial update evaluating the immunogenicity, safety, and lot-to-lot consistency of LBVD, a fully liquid hexavalent DTaP-HepB-IPV-Hib vaccine, in hea…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diphtheria
• Haemophilus Influenzae Type Disease
• Hepatitis B
• Pertussis
• Poliomyelitis
• Tetanus

Drugs mentioned

• LBVD (Hexavalent diphtheria-tetanus-whole cell pertussis-hepatitis B-poliovirus-Haemophilus influenzae type b conjugate vaccine)

Snippet

Sponsor: LG Chem | Conditions: Diphtheria, Tetanus | Phase 2, Phase 3 | Status: RECRUITING